What is Corista?
Corista specializes in digital pathology software, offering the DP3 platform designed to enhance image management and streamline workflows for healthcare and life sciences. Their solutions are tailored for pathologists, providing tools for efficient collaboration, data analysis, and case management. The platform integrates seamlessly with various imaging tools and systems, ensuring a comprehensive approach to pathology workflows. Corista aims to improve efficiency and reduce turnaround times in pathology through advanced technology and real-time collaboration.
How much funding has Corista raised?
Corista has raised a total of $400K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Corista
PPP
Public-Private Partnership
What's next for Corista?
With a substantial total funding amount and a recent strategic investment, Corista is well-positioned for its next phase of growth. The company's focus on enhancing digital pathology workflows suggests potential for further platform development, market penetration into new healthcare systems, and expansion of its collaborative features. This late-stage funding context indicates a strategic push towards scaling operations and solidifying its market leadership in the digital pathology sector.
See full Corista company page
